Doximity beats Q3 revenue expectations

Reuters
Feb 06
Doximity beats Q3 revenue expectations 

Overview

  • Digital platform's fiscal Q3 revenue rose 10% yr/yr, beating analyst expectations

  • Adjusted EBITDA for fiscal Q3 beat analyst expectations

  • Company authorized $500 mln stock repurchase program

Outlook

  • Doximity projects fiscal Q4 revenue between $143 mln and $144 mln

  • Company expects fiscal year revenue between $642.5 mln and $643.5 mln

  • Doximity anticipates fiscal Q4 adjusted EBITDA between $63.5 mln and $64.5 mln

Result Drivers

  • AI INTEGRATION - Co attributed increased platform utility and engagement to the addition of AI features, with over 300,000 users engaging with AI products

  • RECORD ENGAGEMENT - Co reported record quarterly engagement with 1 million active prescribers and 720,000 using workflow products

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$185.05 mln

$182.20 mln (18 Analysts)

Q3 Net Income

$61.56 mln

Q3 Adjusted EBITDA

Beat

$111.40 mln

$104.66 mln (17 Analysts)

Press Release: ID:nBw7wW2k4a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10